price capping, page-6

  1. 534 Posts.
    lightbulb Created with Sketch. 85
    Share price has certainly picked up this week. Bioshares in it's latest edition has Acrux as one of it's top 5 stock picks.

    Bioshares Comments:
    Acrux has appointed Credit Suisse as a corporate advisor to assist with the commercialization of the company's Axiron product. That Acrux has selected Credit Suisse rather than a more traditional biotech investment bank would suggest that an outright acquistion of the company is more likely than a licensing deal for Axiron. It would also seem to suggest that interest in Axiron and in Acrux is escalating and that the company needs assistance to negotiate the sale or license of company assets.

    Perhaps these comments from Bioshares have been a driver of ACR's share price this week

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.8¢
Change
-0.002(10.0%)
Mkt cap ! $7.366M
Open High Low Value Volume
1.8¢ 1.8¢ 1.8¢ $8.471K 470.6K

Buyers (Bids)

No. Vol. Price($)
1 50000 1.8¢
 

Sellers (Offers)

Price($) Vol. No.
2.0¢ 370600 1
View Market Depth
Last trade - 13.32pm 25/07/2025 (20 minute delay) ?
ACR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.